Dr. Zahra, AML expert from Miami Cancer Institute, discusses the importance of patient education and supportive care for acute myeloid leukemia (AML) patients. She emphasizes the need for personalized therapy based on molecular mutations and prognosis, as well as the importance of specialized centers that can provide 24-hour care and transfusion support. Dr. Zahra also highlights the significance of clinical trials in providing newer and potentially better therapies for AML patients.
In acute myeloid leukemia, I think one of the most important aspects of the disease is actually educating the patient. We do a lot in our clinic in terms of teaching the patient about their leukemia, different mutations, and the cytogenetic molecular changes they have.
There's so much about AML that we're learning. I tell my patients a lot that it's a very heterogeneous disease. You can have 200 people with AML in the room, and everybody has a different disease. We really focus on trying to educate patients on their molecular mutations and their prognosis and really try to strategize with our patients to provide the appropriate treatment.
I believe that supportive care for an AML patient is extremely important. I make sure that the patient has the supportive care that they need after intensive therapy. We work to prevent infections, treat them appropriately, and provide 24-hour care in terms of transfusion support, infection control, and management to prevent catastrophic outcomes that can happen when somebody's getting intensive therapy.
Clinical trials are extremely important. Having the opportunity to be on a clinical trial and receiving a newer therapy that could potentially be better is something that we greatly support. Providing the appropriate treatment for the patient is extremely important, but we also want to ensure they have a successful outcome.
A specialized center that focuses on acute leukemia is extremely important so that the patients are being cared for with that higher level of care. I can't stress it enough for our patients – really focus on appropriate transfusion support and monitoring for neutropenic fever, which can be catastrophic if it occurs. Oftentimes patients don't realize that just having chills is enough to be classified as neutropenic fever, and they're not aware of the signs and the symptoms to be monitored for. If I were to have my family treated somewhere, I would recommend a specialized center that is equipped to have the supportive care that an acute leukemia patient needs.
Create a free account to access all our video resources and watch world-renowned AML experts explain the disease and current treatment options.
Visit Healthtree University for AML
Dr. Zahra, AML expert from Miami Cancer Institute, discusses the importance of patient education and supportive care for acute myeloid leukemia (AML) patients. She emphasizes the need for personalized therapy based on molecular mutations and prognosis, as well as the importance of specialized centers that can provide 24-hour care and transfusion support. Dr. Zahra also highlights the significance of clinical trials in providing newer and potentially better therapies for AML patients.
In acute myeloid leukemia, I think one of the most important aspects of the disease is actually educating the patient. We do a lot in our clinic in terms of teaching the patient about their leukemia, different mutations, and the cytogenetic molecular changes they have.
There's so much about AML that we're learning. I tell my patients a lot that it's a very heterogeneous disease. You can have 200 people with AML in the room, and everybody has a different disease. We really focus on trying to educate patients on their molecular mutations and their prognosis and really try to strategize with our patients to provide the appropriate treatment.
I believe that supportive care for an AML patient is extremely important. I make sure that the patient has the supportive care that they need after intensive therapy. We work to prevent infections, treat them appropriately, and provide 24-hour care in terms of transfusion support, infection control, and management to prevent catastrophic outcomes that can happen when somebody's getting intensive therapy.
Clinical trials are extremely important. Having the opportunity to be on a clinical trial and receiving a newer therapy that could potentially be better is something that we greatly support. Providing the appropriate treatment for the patient is extremely important, but we also want to ensure they have a successful outcome.
A specialized center that focuses on acute leukemia is extremely important so that the patients are being cared for with that higher level of care. I can't stress it enough for our patients – really focus on appropriate transfusion support and monitoring for neutropenic fever, which can be catastrophic if it occurs. Oftentimes patients don't realize that just having chills is enough to be classified as neutropenic fever, and they're not aware of the signs and the symptoms to be monitored for. If I were to have my family treated somewhere, I would recommend a specialized center that is equipped to have the supportive care that an acute leukemia patient needs.
Create a free account to access all our video resources and watch world-renowned AML experts explain the disease and current treatment options.
about the author
Katie Braswell
Katie joined HealthTree as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.